<span item_type="fundamental" item_id="5bba1076610bf686535b44ba0c311fe9" counter_id="ST/US/LPAAW" env="prod"></span><span item_type="announcement" item_id="582440828032521729" env="prod"></span><p>Revenue: As of FY2025 Q3, the actual value is USD 0.</p><p>EPS: As of FY2025 Q3, the actual value is USD 0.07.</p><p>EBIT: As of FY2025 Q3, the actual value is USD -3.074 M.</p><p></p><h3>Segment Revenue</h3><ul><li><strong>Interest Earned on Trust Account</strong>: For the three months ended September 30, 2025, interest earned on cash and marketable securities held in the Trust Account was $2,556,473, and for the nine months ended September 30, 2025, it was $7,553,223.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/2015502/000121390025110031/ea0264936-10q_launch1.htm"></span></li></ul><h3>Operational Metrics</h3><ul><li><strong>Net Income</strong>: For the three months ended September 30, 2025, net income was $2,011,042, and for the nine months ended September 30, 2025, it was $6,220,473.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/2015502/000121390025110031/ea0264936-10q_launch1.htm"></span></li><li><strong>General and Administrative Expenses</strong>: For the three months ended September 30, 2025, these expenses were $517,261, and for the nine months ended September 30, 2025, they were $1,333,140.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/2015502/000121390025110031/ea0264936-10q_launch1.htm"></span></li></ul><h3>Cash Flow</h3><ul><li><strong>Net Cash Used in Operating Activities</strong>: For the nine months ended September 30, 2025, net cash used in operating activities was - $752,686.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/2015502/000121390025110031/ea0264936-10q_launch1.htm"></span></li></ul><h3>Unique Metrics</h3><ul><li><strong>Trust Account Balance</strong>: As of September 30, 2025, the balance in the Trust Account was $243,082,744, including interest income.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/2015502/000121390025110031/ea0264936-10q_launch1.htm"></span></li></ul><h3>Future Outlook and Strategy</h3><ul><li><strong>Core Business Focus</strong>: The company plans to complete a Business Combination before the end of the Combination Period, which is July 15, 2026. The management is focused on consummating the Minovia Business Combination, which involves merging with Minovia Therapeutics Ltd. and becoming a wholly-owned subsidiary of Pubco, a publicly traded company.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/2015502/000121390025110031/ea0264936-10q_launch1.htm"></span></li><li><strong>Non-Core Business</strong>: The company is also involved in bridge financing efforts to raise at least $5 million for Minovia at a pre-money equity valuation of $120 million, as part of the Minovia Business Combination Agreement.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/2015502/000121390025110031/ea0264936-10q_launch1.htm"></span></li></ul>

LAUNCH ONE ACQUISITION CORP C/ WTS 01/06/2031 (TO PUR ORD) | 10-Q: FY2025 Q3 Revenue: USD 0